HighTower Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$388K Buy
+8,397
New +$385K ﹤0.01% 2964
2025
Q4
– Sell
-6,273
Closed -$295K – 3718
2025
Q3
$295K Sell
6,273
-415
-6% -$21.5K ﹤0.01% 3058
2025
Q2
$348K Buy
6,688
+147
+2% +$8.07K ﹤0.01% 2800
2025
Q1
$395K Sell
6,541
-265
-4% -$17.1K ﹤0.01% 2651
2024
Q4
$466K Sell
6,806
-250
-4% -$17.4K ﹤0.01% 2527
2024
Q3
$512K Buy
7,056
+275
+4% +$19.4K ﹤0.01% 2381
2024
Q2
$472K Buy
6,781
+109
+2% +$7.95K ﹤0.01% 2368
2024
Q1
$530K Sell
6,672
-23,375
-78% -$2.08M ﹤0.01% 2241
2023
Q4
$3.29M Buy
30,047
+23,255
+342% +$2.4M 0.01% 1168
2023
Q3
$685K Sell
6,792
-416
-6% -$47.8K ﹤0.01% 2010
2023
Q2
$977K Buy
7,208
+492
+7% +$60.1K ﹤0.01% 1769
2023
Q1
$694K Buy
6,716
+237
+4% +$22.9K ﹤0.01% 1890
2022
Q4
$577K Buy
6,479
+994
+18% +$82.5K ﹤0.01% 2034
2022
Q3
$441K Buy
5,485
+2,651
+94% +$250K ﹤0.01% 2101
2022
Q2
$272K Buy
2,834
+45
+2% +$5.4K ﹤0.01% 2424
2022
Q1
$415K Sell
2,789
-4
-0.1% -$559 ﹤0.01% 2307
2021
Q4
$396K Buy
2,793
+57
+2% +$8.07K ﹤0.01% 2306
2021
Q3
$358K Buy
2,736
+991
+57% +$130K ﹤0.01% 2297
2021
Q2
$240K Sell
1,745
-74
-4% -$10.1K ﹤0.01% 2542
2021
Q1
$234K Buy
+1,819
New +$219K ﹤0.01% 2478
2019
Q2
– Sell
-13,912
Closed -$1.15M – 2403
2019
Q1
$1.15M Buy
+13,912
New +$1.01M 0.01% 1082
2018
Q3
– Sell
-13,451
Closed -$986K – 2311
2018
Q2
$986K Buy
+13,451
New +$915K 0.01% 1119

Other funds holding CNMD

HighTower Advisors's CNMD Position: Q3 2026 in Review

HighTower Advisors opened a new position in CONMED (CNMD) in Q3 2026: 8,397 shares worth $388K. The stake represents ﹤0.01% of the portfolio and ranks #2964 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in CNMD as recently as Q3 2025.

HighTower Advisors first reported a position in CNMD in Q2 2018 and has held it in 22 quarters since. The position peaked at $3.29M in Q4 2023. 270 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • HighTower Advisors held 8,397 shares of CONMED worth $388K as of Q3 2026.
  • CONMED was a new HighTower Advisors position in Q3 2026.
  • CONMED made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2964 holding.
  • HighTower Advisors first reported a position in CONMED in Q2 2018 and has held it in 22 quarters since.
  • HighTower Advisors's CONMED position peaked at $3.29M in Q4 2023.
  • 270 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.